Aminopyrimidines as kinase modulators

Details for Australian Patent Application No. 2006258039 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Xu, Guozhang; Baumann, Christian Andrew; Gaul, Michael David

Agent Shelston IP

Pub. Number AU-A-2006258039

PCT Pub. Number WO2006/135719

Priority 60/689,715 10.06.05 US; 60/751,083 16.12.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135719 Priority application(s): WO2006/135719

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258040-Synergistic modulation of FLT3 kinase using thienopyrimidine and thienopyridine kinase modulators

2006258038-Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators